Discover the Leaders Defining the Next Era of TCR Innovation Stefan Scherer Chief Executive Officer & President3T Biosciences Reagan Jarvis Chief Executive Officer & Co-FounderAnocca Qi Zhao Principal ScientistBioNTech Serena Stadler Senior ScientistCaptain T Cell Ricard Masia Senior Director, Translational MedicineCrossbow Therapeutics Joseph Dukes Chief Scientific OfficerEnara Bio Cheng Liu President & Chief Executive OfficerEureka Therapeutics Gene Uenishi Associate Director, DiscoveryGentiBio Cedrik Britten Chief Medical OfficerImmatics Annelise Vuidepot Chief Science & Technology OfficerImmunocore Ke Liu Chief Development OfficerMarengo Therapeutics Zhen Su Chief Executive Officer & DirectorMarengo Therapeutics Inc. Rachel Abbott CEOPan Cancer T David DiLillo Executive DirectorRegeneron Pharmaceuticals Sarah Leonard Vice President, Pre-Clinical DevelopmentT-Cypher Bio Peggy Sotiropoulou CSOT-knife Therapeutics Cassian Yee Director, T-Cell-Based Therapies (ProTCT), Division of Cancer MedicineThe University of Texas MD Anderson Cancer Center Tao Wang Associate Professor, Bioinformatics & Computational BiologyThe University of Texas MD Anderson Cancer Center Mollie Jurewicz DirectorTScan Therapeutics Emilie Gauthy Chief Technology OfficerZelluna Immunotherapy Luise Weigand Chief Scientific OfficerZelluna Immunotherapy Discover the Agenda See the agenda delivering the latest breakthroughs and real-world insights on TCR-T, TCR mimetics, TCR-TCEs, and TCR bispecifics. View Presentations & Speakers Partner With the Future Position your brand at the center of the TCR ecosystem by partnering with leading developers shaping the future of TCR-based therapies. Explore Partnership Options Collaborate With TCR Experts Connect with senior leaders across biopharma and academia during high-value networking sessions and the scientific poster session. Join Your Community